Background. The Coronary Artery Surgery Study (CASS) Registry is used to evaluate the effect of various baseline clinical and angiographic factors on mortality after acute out-of-hospital myocardial infarction (MI) in patients with and without prior coronary bypass surgery.
T he demographics of acute myocardial infarction (MI) and sudden cardiac death have undergone major changes since the mid 1970s. These changes include greater public recognition of acute coronary symptoms deserving of medical attention, greater sensitivity of physicians and emergency departments in admitting patients with possible acute infarction, and more rapidly responsive emergency patient transport services. These changes have the potential effect of providing life-saving care for patients who might have died in the early phase of acute MI and conversely bringing to medical care patients whose mild symptoms and modest clinical findings might previously have been below the threshold of patient or physician recognition.
These demographic changes make it difficult to assess changes in the mortality rate associated with acute MI that have been brought about by new treatments. The evaluation of mortality associated with acute MI has usually been carried out on hospitalized patients. In these studies, changes in the case fatality rates are functions of changing recognition of symptoms and changing criteria for hospitalization as well as changes in therapy. To evaluate real changes in the mortality of MI, it is necessary to estimate the overall mortality rate, which can only be done by including patients with MI who died before reaching medical care.
In the present study, medically and surgically treated patients from the National Heart, Lung, and Blood Institute Coronary Artery Surgery Study (CASS) Registry were followed prospectively for the incidence of MI. Extensive baseline data including clinical and angiographic information were collected in these patients. Knowledge of out-of-hospital and in-hospital acute infarction mortality rates in specific clinical and angiographically defined subsets of patients provides the basis for assessing trends in cardiovascular mortality and for developing guidelines regarding patients who are most likely to benefit from aggressive therapeutic intervention. Moreover, this study helps identify groups of patients who, because of high mortality rates, should be particularly alerted to the symptoms of infarction and the importance of promptly seeking medical attention. Table 3 . The declines over time in out-of-hospital, hospitalized, and 30-day mortality were significant for the period of the study (p=0.02, p=O0.04, and p=0.004; X2 test for linear trend).
Surgical Patients
The incidence rate for MI in CASS surgical patients over the 3 years after first surgery was 10%. Within this period, there were 369 surgical patients who had an MI out of the hospital (Figure 1 ). The rate of hospitalization for the postsurgical patients was similar to the corresponding rate for medically treated patients. Of the postsurgical patients, 298 (81%) were hospitalized. Of these 298 patients, 282 were hospitalized on the day of their infarction and 16 were admitted from 2 to 7 days after their infarction. There were 71 postsurgical patients (19%) who had an MI but were not admitted to the hospital within 30 days. Most of these patients (62%, 44 of 71) died immediately. The 30-day mortality of the 369 postsurgical MI patients was 21% (77 of 369). Of these deaths, 44 occurred immediately out of hospital, five occurred in the emergency room, and 28 occurred in the hospital. There were no deaths after hospital discharge within 30 days. The immediate out-of-hospital mortality rate was 12% (44 of 369); the mortality rate for hospitalized patients was 11% (33 of 298). As was seen in the nonsurgical patients, most of the deaths occurred early, 62 (81%) within 24 hours and 72 (94%) within 1 week of MI.
The immediate and 30-day mortality rates for postsurgical patients are given in Table 4 for various clinical and angiographic characteristics. The presence of left ventricular dysfunction at baseline cardiac catheterization and prior MI were the only factors that significantly increased out-of-hospital mortality rates (p=0.02 for each). In contrast to patients without bypass surgery, the extent of coronary artery disease before bypass surgery did not influence immediate mortality. The 30-day mortality rates were significantly higher for patients with left ventricular dysfunction (p=0.0001) and those with prior MI (p=0.003).
The mortality rates for 298 postsurgical patients who were hospitalized are given in Table 5 . In these patients, as for patients who were not hospitalized, left ventricular dysfunction was significantly related to higher mortality rates.
Case fatality rates for the years 1974-1982 are given in Table 6 . The rates for postsurgical patients did not change significantly over time. 
Comparison of Surgical and Nonsurgical Patients
Case fatality rates were compared in 352 surgical patients and 810 medical patients who met the minimum CASS anatomic criteria for bypass surgery. Patients with normal coronary arteries or with diffuse inoperable disease were not included in these analyses. Clinical and angiographic characteristics of these patients are given in Table 7 . Surgical patients had more two-vessel disease, less left ventricular dysfunction at baseline, and more Canadian Heart class III-IV baseline angina. The proportions of patients with prior MI were similar. Of the prior MIs in the surgical group, 8% were single perioperative infarctions.
For the 1,162 patients in the medical-surgical comparison, ECG information was not available for 258 patients who were not admitted to the hospital (most of whom died immediately), for 28 patients who died in the emergency room, or for 56 hospitalized patients for whom the information was not available for other reasons. ECG data were analyzed for the remaining 558 (69%) medical patients and 262 (74%) surgical patients. For these subsets of patients, the percentages of Q wave infarctions were 42% in the medical group and 36% in the surgical group (p=0.10).
Case fatality rates were much higher in patients who had not had bypass surgery. The immediate out-ofhospital rates were 13% and 21%, respectively, for patients with and without surgery (p=0.001); the 30-day rates for hospitalized patients were 12% and 24% (p<O.OOOl). in patients with bypass surgery and 40% in patients without bypass surgery (p<0.0001). These differences in mortality rates could have been due to differences in the populations of medically and surgically treated patients. The comparisons of mortality rates for medical and surgical patients were adjusted by logistic regression for age, extent of disease, left ventricular dysfunction, angina, prior MI, and sex. After these adjustments, the differences in mortality rates between medicine and surgery remained significant (immediate mortality, tion of hospital and subsequent mortality, ignoring those deaths that occurred before hospitalization, or to a combination of hospital and late mortality coupled with an assessment of presumed sudden cardiac deaths that occurred in a community during the same period of time. In two such studies published two decades ago, the prehospital mortality was estimated to be 20% and 25%.3,4 These case fatality rates from an era before the development of coronary artery bypass surgery are remarkably similar to the 21% immediate mortality rate observed in CASS nonsurgical patients before 1980.
There are numerous studies of hospital mortality associated with MI in the older and more recent literature. Between 1962 and 1981, there was a wide variation in reported mortality from only 16% to 41%.5-10 In one large study, the 7-day mortality was 39% in the early 1960s and remained at that level in the late 1960s. Studies that compared men and women before the advent of bypass surgery showed little difference in mortality rates. In the Edinburgh study,3 the rates were 15% for men and 17% for women for medically attended deaths. In the Australian study,4 the in-hospital case fatality rates were 22% for men and 21% for women. A more recent study from Israel reported age-adjusted in-hospital mortality rates of 23% for women and 16% for men (p<0.0005).17 Angiographic characteristics were not used in this study, and the presence of coronary bypass surgery was not noted. It is possible that some of the difference between men and women observed in the Israeli study is due to a difference in use of coronary bypass surgery. In one report, the use of revascularization surgery was 45% higher in men than in women.'8 Based on the findings in the CASS study, a reduced use of surgery in women would be expected to increase the case fatality rate for MI in women. Within CASS cohorts of medical and surgical patients, the case fatality rates for men and women were similar. For medical patients, the mortality rates in hospitalized patients were 22% for men and 19% for women (p=0.49). For surgical patients, the rates were 11% for men and 13% for women (p=0.67).
The use of ,3-blockers and aspirin before MI was associated with only slightly reduced mortality, and none of the differences were statistically significant.
Although ,3-blockers have been shown to reduce mortality when prescribed after MI,19-21 the data presented here indicate that ,l-blockers probably do not reduce the mortality associated with a subsequent MI. Similarly, although aspirin has been shown to reduce the incidence of MI,22 these data as well as other studies23 indicate that the mortality from MI, when it occurs, is not reduced by prior aspirin administration. The CASS data on 3-blockers and aspirin should be interpreted with caution, because patients' use of drug at the last Many studies have shown an association between cigarette smoking and coronary artery disease. Cigarette smoking is associated with increased mortality in patients with coronary artery disease24 and is associated with sudden death in patients who have survived an episode of ventricular fibrillation. 25 In this study, cigarette smoking did not increase the risk of mortality in patients with MI. In this population, 62% of the medical group and 55% of the surgical group were smokers at the time of last annual follow-up, whereas in the complete CASS Registry, only 33% were smokers at baseline. The relatively high proportion of smokers in patients with MI supports the association between cigarette smoking and the incidence of acute MI, but these data indicate that patients who smoke are no less likely to survive their MI than those who do not smoke.
In summary, we have evaluated the influence of baseline clinical and angiographic characteristics and of coronary bypass surgery on case fatality rates of patients who had an MI after entry into the CASS Registry. As expected, the severity of left ventricular dysfunction and number of vessels diseased had an important influence on mortality from subsequent MI in medical patients. In the surgically managed patients, left ventricular dysfunction was also a major determinant of outcome, but the number of vessels diseased was not. The case fatality rate for patients with MI was much lower in patients who had had coronary bypass surgery. This difference may possibly be explained by smaller infarct size in surgical patients. Of special interest was the small group of 27 patients in the medical group who had normal coronary arteries at baseline. These patients experienced an unexpectedly high out-of-hospital mortality of 19% -higher than all except the rate for the subset of patients with threevessel disease -suggesting that the absence of preexisting collateral circulation may increase the risk of sudden death in such patients. Patients on 13-blockers or aspirin before MI did not have a lower mortality than those not on these drugs. Cigarette smoking was more common in this group of patients who had an MI than in CASS patients who did not have an MI, but smoking was not associated with increased mortality from MI.
